note ||| Copyright �ERS Journals Ltd 1999 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
note ||| European Respiratory Journal |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| ISSN 0903-1936 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| Eur Respir J 1999; 14: 302-308 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
note ||| Printed in UK — all rights reserved |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| Development of wheezing in patients with cough variant asthma |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_largest0 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| during an increase in airway responsiveness |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_largest0 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
author ||| Y.Y. Koh*, J.H. Jeong*, Y. Park*, C.K. Kim** |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_largest-1 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Development of wheezing in patients with cough variant asthma during an increase in |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| airway responsiveness. Y.Y. Koh, J.H. Jeong, Y. Park, C.K. Kim. �ERS Journals Ltd 1999. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ABSTRACT: Two theories explaining the mechanism for the manifestation of cough |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| without wheeze in patients with cough variant asthma (CVA) are either a higher |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing threshold or a milder degree of airway hyperresponsiveness. A significant |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| proportion of patients diagnosed as having CVA eventually develop wheezing. The |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| aim of this study was to investigate whether this change in the manifestation of asthma |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was associated with a decrease in wheezing threshold and/or an increase in airway |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| hyperresponsiveness. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Thirty-six children (7-15 yrs) with CVA were prospectively studied for 4 yrs. Bron- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| chial provocation tests with methacholine using the stepwise increasing concentra- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tion technique were performed annually to measure the provocative cumulative dose |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| producing a 20% fall in forced expiratory volume in one second (PD20). Wheezing |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| thresholds were additionally determined at the initiation of and the end of the study |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (development of wheezing, or after 4 yrs). |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Sixteen (Group 1) of 29 patients available for the follow-up developed clinical |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| wheezing during the period; 13 patients (Group 2) stayed as CVA or their cough |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| resolved. There was no significant change in wheezing thresholds from the initiation to |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the end of the study (Group 1: 40.9�8.2% versus 40.2�8.3%; Group 2: 41.4�7.1% |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| versus 40.1�7.3%). Methacholine PD20 (geometric mean, range of 1 SD), expressed as |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| breath unit (BU), significantly decreased in Group 1 patients as they developed |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing (initial versus wheezing year: 60.8 BU, 29.2-126.5 versus 32.8 BU, 11.5-93.3; |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| p&lt;0.01), whereas the value did not change in Group 2 patients (initial versus after 4 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| yrs: 85.3 BU, 45.2-161.1 versus 84.3 BU, 39.7-179.1; Ns). |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The results suggest that an increase in airway hyperresponsiveness, but not a |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| decrease in wheezing threshold, may have a pathogenetic role in the development of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing during the course of cough variant asthma in childhood. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Eur Respir J 1999; 14: 302-308. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
affiliation ||| *Dept of Pediatrics, Seoul National Uni- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
affiliation ||| versity College of Medicine, and **Dept |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
affiliation ||| of Pediatrics, Inje University Sanggye |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
affiliation ||| Paik Hospital, Seoul, Korea. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| Correspondence: Y.Y. Koh |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
affiliation ||| Department of Pediatrics |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
affiliation ||| Seoul National University Children's Hos- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
affiliation ||| pital |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
address ||| 28 Yongon-dong |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
address ||| Chongno-gu |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
address ||| Seoul 110-744 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
address ||| South Korea |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| Fax: 82 27475130 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
keyword ||| Keywords: Airway hyperresponsiveness |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
keyword ||| cough variant asthma |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
keyword ||| wheezing |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
keyword ||| wheezing threshold |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
note ||| Received: October 20 1998 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
note ||| Accepted after revision November 7 1998 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
note ||| This study was supported by grant No. 04- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
note ||| 98-029 from the Seoul National University |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| Research Fund. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Cough variant asthma (CVA) is an occult form of asth- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| ma in which the only sign or symptom is chronic cough |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| [1]. It is a common problem amongst all ages that fre- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| quently goes unrecognized, leading to underdiagnosis |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and undertreatment [2]. The main reason of underdiagno- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sis or delayed diagnosis in patients with CVA is thought |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| to be a lack of wheezing detected by the patients and/or |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| physician, because wheezing has long been considered |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the sine qua non of asthma [3]. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Cough is an important part of the symptom complex in |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| most asthmatic patients. Wheezing is a dynamic sign, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| occurring when flow through narrowed airways creates |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| vibrations in the audible frequency [4]. In the investigation |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of the possible mechanism for the manifestation of cough |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| without wheeze in patients with CVA, it has been dem- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| onstrated that they had a higher wheezing threshold (the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| minimal degree of airway obstruction when wheezing |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| becomes audible) than those who report both cough and |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheeze (classic asthma (CA)) [5]. Another theory for the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| manifestation is that CVA probably represents the milder |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| end of the spectrum of asthma, reflecting a milder degree |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of airway hyperresponsiveness [1, 6]. Since variability of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| airflow obstruction is low in this circumstance, symptoms |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of airflow obstruction such as wheeze, are unlikely to |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| occur [7]. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Some studies have indicated that CVA may be a |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| forerunner of CA [8, 9, 10]. HANNAWAY and HOPPER [9], |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and KONIG [10] found that typical attacks of wheezing |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| developed in a significant number of children (80% and |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 75%, respectively) when followed for several months to 8 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| yrs. The current authors have also observed many patients |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with CVA, who began to wheeze within a few years after |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| follow-up. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| It was reasoned that the patients with CVA may re- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| present a subset of asthmatics whose airways are less able |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| to produce a wheeze and they may present as CA when the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| variable airway obstruction exceeds the threshold to |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| generate wheeze. This may result from two concepts: |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| firstly, the wheezing threshold may become reduced to a |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| range of CA so that the variable airway obstruction can |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| have a chance to produce audible wheezing; and, secondly, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| airway hyperresponsiveness may be enhanced during the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| course of CVA so that the increased variable airway |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| obstruction can pass over the wheezing threshold. It was |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| hypothetized that the development of wheezing in patients |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with CVA, i.e., conversion to CA was associated with a |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| WHEEZING AND INCREASE IN AIRWAY RESPONSIVENESS	303 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| decrease in wheezing threshold and/or an increase in air- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| way hyperresponsiveness. In order to test this hypothesis, |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| children with CVA were prospectively studied, and the |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| changes in wheezing threshold and methacholine reactivity |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were examined according to whether they developed |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sectionHeader ||| Materials and methods |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_larger xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Thirty-six children with CVA were enrolled in the study. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Initially, they were referred to the pulmonary clinic for the |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| chronic cough, which had persisted for &gt;2 months (range: |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 9 weeks to 2 yrs). The cough was usually dry or productive |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with scant amount of clear sputum and was mostly |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| nocturnal. None of them had a wheeze nor a prolonged |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| expiratory phase on physical examination. Normal results |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were found for the following tests: chest radiograph, spiro- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| metry, sinus films, and tuberculin skin tests. All patients |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| responded significantly to a trial of oral theophylline 20�24 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| mg•kg•day- 1. All of them were recorded as having bron- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| chial hyperreactivity (table 1). Skin-prick tests were per- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| formed, and atopy was defined by the presence of at least |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| one positive reaction (&gt;3 mm wheel diameter) with a |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| battery of 15 common airborne allergens. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The prospective study was performed between Decem- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| ber 1991 and February 1996. At the initiation of the study, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| bronchial provocation tests with methacholine were per- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| formed to measure bronchial reactivity and wheezing |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| threshold. For the follow-up, patients were asked to attend |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the clinic every 3 months whenever possible, for clinical |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| assessment and medication adjustment. At each atten- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dance, patients were questioned about symptoms and signs |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in the interim, and a physical examination was performed |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| if appropriate. Additional contact with each subject was |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| made when wheezing was perceived by the patient or the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patient's parents for the first time. Wheezing was defined |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| as a whistling sound coming from the chest but not the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| throat, which had been demonstrated in the procedure of |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the initial bronchial provocation test. The development of |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing was documented in each individual when the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| Table 1. — Baseline characteristics of subject groups at |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_larger xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| the initiation of study |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_larger xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Group 1	Group 2	Dropped-out |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
table ||| n	16	13	7 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Mean age 	9.6(7-14)	10.2 (7-15)	10.0 (8-13) |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| (Range) yrs |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Sex M/F n	9/7	7/6	3/4 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Atopy, n%	10 (62.5)	8(61.5)	4(57.1) |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| FEV1 %predicted*	94.8�7.6	95.2�6.9	97.3�7.5 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Initial bronchial provocation test |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
table ||| Methacholine	60.8	85.3	131.5 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| PD20 BUt	(29.2-126.5)	(45.2-161.1)	(88.1-196.3) |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Wheezing	41.4�7.1	38.1�6.3 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| threshold %*	40.9�8.2 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| Those patients who developed wheezing during the course of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| follow-up period were listed as Group 1; those who did not were |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| listed as Group 2. *: mean�SD; t: geometric mean, and range of 1 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| SD in parenthesis. M: male; F: female; FEV1: forced expiratory |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| volume in one second; PD20: provocative cumulative dose |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| producing a 20% fall in FEV1; BU: breath unit (1 BU denotes |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| one inhalation of 1 mg•mL-1 methacholine). |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| claims of subjective wheezing were verified by a phy- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| sician's careful auscultation. In each calendar year, each |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patient was overall clinically assessed, and one of the |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| three phases of symptom presentation was assigned: 1) |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing phase, if an attack of wheezing was documented |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| at any time during the last 12 months; 2) cough phase, if a |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patient had suffered from persistent cough for at least 2 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| weeks (occurring particularly at night, early in the morning |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| or after exercise, with reduction after administration of |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| bronchodilators); and 3) symptom-free phase, if a patient |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| had experienced neither wheezing nor coughing. Metha- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| choline reactivity was measured at the end of each year for |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| all patients. In view of the fact that most of the atopic |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patients were sensitized predominantly to house dust mites, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| it was decided to perform the bronchial provocation test |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| during the winter season (December to February) during |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| which time the levels of house dust mites have been found |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| to be the lowest and the least changing in South Korea |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| [11]. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| During the study, subjects were instructed to keep their |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| cough symptom well controlled by minimum use of in- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| haled bronchodilators. They were asked to avoid major |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| environmental changes, and if their parents were smokers, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| to keep their consumption constant. Those subjects who |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| developed wheezing during the follow-up were treated |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with intermittent bronchodilator, and some of them were |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| additionally given inhaled cromolyn sodium (n=6) or in- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| haled corticosteroid (n=4) according to the National Insti- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tutes of Health (NIH) guidelines [12]. The patients were |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| brought to an end of the study by undergoing bronchial |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| provocation tests for the measurement of methacholine |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| reactivity and wheezing threshold at the end of the year of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing phase. Those subjects who did not develop |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing used the same bronchodilator throughout the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| study. These patients were assessed annually for metha- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| choline reactivity, and at the end of study (after 4 yrs of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| follow-up) for not only methacholine reactivity but also |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing threshold. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| For comparison of methacholine reactivity and wheez- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| ing threshold, a separate group of 13 patients with mild |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| asthma (CA with wheezing history) were recruited. These |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patients underwent bronchial provocation test on one oc- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| casion. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| High-dose methacholine inhalation tests were carried |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| out using a modification of the method described by CHAI |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| et al. [13]. Each patient attended for methacholine chal- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lenge at the same time of day on every occasion to avoid |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| any circadian variation in reactivity [14]. All of the chal- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lenge tests were performed by a single investigator who |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was blinded to clinical status. All patients were asked to |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cease using inhaled bronchodilator or other medications |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 24 h, oral theophylline 48 h, and inhaled cromolyn sod- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ium or inhaled corticosteroid 7 days, respectively, before |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the test. At the time of the test, all patients had been free |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of acute respiratory tract infection for 4 weeks. On each |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| day of the test, lung function was measured in tripli- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cates with a computerized spirometer (Microspiro-HI |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 298; Chest, Tokyo, Japan) after rests of 30 min between |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| each test, and the study was continued only if the base- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| line forced expiratory volume in one second (FEV1) was |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| at least 70% of the predicted value [15]. The largest value |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of the triplicate FEV1 at each time was used for analysis. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The concentrations (0.075, 0.15, 0.3, 0.625, 1.25, 2.5, 5, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 10, 25, 50, 100, 150 and 200 mg•mL-1) of methacholine |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| 304	Y.Y. KOH ET AL. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| (Sigma Chemicals, St. Louis, MO, USA) were prepared |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| by dilution in buffered saline (pH 7.4). A Rosenthal- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| French dosimeter (Laboratory for Applied Immunology, |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Baltimore, MD, USA), triggered by a solenoid valve set |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| to remain open for 0.6 s, was used to generate the aerosol |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| from a DeVilbiss 646 nebulizer (DeVilbiss, Somerset, PA, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| USA), with pressurized air at 13.8 kPa (20 psi). Each |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| subject inhaled five inspiratory capacity breaths of nebu- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lized buffered saline and increasing concentrations of |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| methacholine at 5 min intervals. This gave an output of |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 0.009�0.0014 mL (mean�SD) per inhalation. FEV1 was |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| measured at 60-90 s after each inhalation. The inhalation |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was continued until FEV1 fell by &gt;20% from the post- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| saline value. The percentage fall of FEV1 from the mean |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| postsaline value was plotted against log cumulative dose |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of inhaled methacholine expressed as breath unit (BU). |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| One BU denotes one inhalation of 1 mg•mL-1 methacho- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| line. The provocative cumulative dose of methacholine |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| producing a 20% fall in FEV1 (PD20) was calculated by |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| interpolation between two adjacent data points. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The test that measured wheezing threshold also included |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| breath sound auscultation at baseline and at each stage of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| serial inhalation. While the children were quietly breath- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ing, the same physician performed breath sound auscul- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tation using a regular paediatric stethoscope for —30 s |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| beginning just after each measurement of lung function. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| After the fall in FEV1 become &gt;20%, the next increment in |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| methacholine was half of the usual amount. The inhalation |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| continued until wheezing was clearly heard over the tra- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| chea, or until FEV1 fell by &gt;50% from the postsaline value, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| or until three or more data points of highest concentrations |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fell within a 5% response range, i.e., maximal response |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| plateau occurred [16]. For safety reasons, subjects were |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| given the opportunity to stop the challenge test if they felt |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| too much discomfort. Wheezing threshold was defined as |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the percentage fall in FEV1 at the minimal methacholine |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dose at which wheezing was first detected; whereas it was |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| defined as the final value of percentage fall in FEV1, if |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| FEV1 fell by more than 50% or maximal response plateau |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| occurred without wheezing. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The study was approved by the Hospital Ethics |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| Committee, and the parents of the children in the study |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| gave their informed consent. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Statistical analysis |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Mean and standard deviation values were calculated for |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| analysis. All PD20 values were log-transformed before |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| analysis. Student's t-tests or Wilcoxon rank sum tests were |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| used to analyse the difference in the variables between the |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| two groups. Comparisons of PD20 or wheezing threshold |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| between the 2 yrs were analysed for each group, using |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| paired t-tests or Wilcoxon signed rank tests. All of the |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| analyses were made using Stat View II (Abacus Concept |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Inc., Berkeley, CA, USA) on a Macintosh computer |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (Apple Computer Inc., Cupertino, CA, USA). A p-value |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of &lt;0.05 was considered statistically significant. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sectionHeader ||| Results |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_larger xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| At the initiation of the study, wheezing threshold and |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| methacholine PD20 were compared between CVA (n=36) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and CA (n=13) (fig. 1). There was no significant dif- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ference in baseline FEV1 between the two groups (92.9� |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 7.3% predicted versus 89.8�9.0% pred) (data not shown). |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Wheezing was not audible in the provocation procedure |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with a percentage fall in FEV1 &gt;50% (two cases of CVA) |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| or with maximal response plateau (five cases of CVA and |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| two cases of CA). With the censored value (last value of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| percentage fall in FEV1) in these cases, wheezing |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| threshold was significantly (p&lt;0.01) higher in CVA |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (40.6�7.4%) than in CA (31.3�8.9%). When these cases |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were excluded from the analysis, the difference was still |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| statistically significant (41.1 �6.8% in CVA versus |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 31.6�9.6% in CA, p&lt;0.01) (data not shown). Geometric |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| mean (range of 1 SD) of methacholine PD20 in CVA was |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 79.8 BU (40.0-159.6), and that in CVA was 60.8 BU |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (40.5-91.2). This difference did not reach significance |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (p=0.10). |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Of the 36 patients with CVA enrolled in the study, seven |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| were lost to follow-up although every effort was made to |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| continue the regular check-ups. Three patients dropped out |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of the study in the second year; two in the third year; and |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| two in the fourth year. In the year just before drop-out, 4 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patients were in cough phase; three were in symptom-free |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| phase. The characteristics of the subjects who completed |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the study, as well as the patients who were lost, are |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| a) |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 60 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 50 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 40 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 30 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 20 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 10 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 0 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| b) |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 1000 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 100 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 10 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 1 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| CVA	CA	CVA	CA |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| Fig. 1. — Comparison of a) wheezing threshold and b) methacholine provocative cumulative dose producing a 20% fall in forced expiratory volume |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| in one second (FEV 1) (PD20) between cough variant asthma (CVA) (n=36) and classic asthma (CA) (n=13). Mean�1SD are indicated with horizontal bars. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| 0: fall in FEV1 &gt;50% without wheezing; 0: maximal response plateau without wheezing; O wheezing threshold; BU: breath unit (one BU denotes one |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| inhalation of 1 mg•mL-1 methacholine). |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| WHEEZING AND INCREASE IN AIRWAY RESPONSIVENESS	305 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| summarized in table 1. Those who developed wheezing |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| during the course of follow-up were listed as Group 1; |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| those who did not were listed as Group 2. The patients |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| who dropped out of the study did not significantly differ |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| from those completing the study (Group 1 and 2) with |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| respect to age, sex, prevalence of atopy or FEV1 level. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Methacholine PD20 in the initial bronchial provocation |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| test was significantly (p&lt;0.01) higher in the drop-out |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| group than in the Groups 1 and 2 combined, whereas |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing thresholds were similar. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The pattern of symptom presentation and individual |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| PD20 in each year during the course of follow-up are |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| presented in table 2. Among the Group 1 patients, 3 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| subjects developed wheezing in the first year, 4 in the |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| second year, 6 in the third year, and 3 in the fourth year. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Among the Group 2 patients, 6 subjects continued to be in |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cough phase, 5 subjects alternated cough phase with |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| symptom-free phase, and 2 subjects had symptom-free |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| phase during the last 2-3 yrs. The initial PD20 values |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were not significantly different between the two groups. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Nine annual PD20 data, four in Group 1 and five in Group |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 2, were not available due to failure to attend the test in the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fixed period or due to upper respiratory tract infection |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| within the 4 weeks preceding the test. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| Table 2. - The pattern of symptom presentation and |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_larger xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| individual provocative cumulative dose producing a 20% |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_larger xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| fall in forced expiratory volume in one second |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_larger xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Subject 	Initial 	Follow-up |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
table ||| No.	test |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 1st yr	2nd yr	3rd yr	4th yr |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Group 1 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 1	25.0	W 10.2 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 2	63.5	W 100.6 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 3	81.2	W 58.8 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 4	13.8	C 30.6	W 11.2 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 5	34.1	C 22.4	W 23.2 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 6	39.1	C 38.2	W 14.4 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 7	92.7	C39.6	W31.5 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 8	20.8	C12.3	C15.1	W3.8 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 9	50.4	C ND	C 67.2	W 119.9 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 10	68.4	C 110.6	C ND	W 23.0 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 11	97.6	C 53.7	C 31.3	W 33.4 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 12	116.9	C ND	C 234.1	W 40.1 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 13	154.7	C 341.5	C 163.9	W 97.6 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 14	60.3	C 47.2	C 72.5	C 76.3	W 16.0 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 15	121.2	C96.4	C112.7	CND	W171.4 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 16	169.6	C 145.3	C 198.8	C 155.8	W 67.0 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Group 2 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 1	18.6	C24.6	C47.8	C32.0	C60.5 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 2	39.7	C ND	C 87.4	C 29.1	C 53.4 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 3	56.0	C 58.9	C 27.3	C 62.6	C 36.1 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 4	71.3	C 106.2	C 85.9	F 54.8	C 47.2 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 5	78.3	C 60.7	F 132.1	C ND	C 33.9 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 6	84.5	C 101.9	C 80.4	F 142.5	F 105.3 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 7	88.1	C ND	C 54.5	C 69.3	C 28.8 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 8	102.9	C 83.6	F 39.7	F 56.6	F 243.4 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 9	110.4	F 130.6	C ND	C 98.3	F 132.6 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 10	143.7	C 65.4	C 92.6	C 163.1	C 180.9 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 11	147.8	C 203.2	F 89.5	C 167.4	C 102.5 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 12	165.9	C 148.0	C 76.9	C 159.3	C 265.5 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 13	184.6	C 127.6	C 200.4	F ND	C 120.4 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| Data presented in breath units (BU; 1 BU denotes one inha- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| lation of 1 mg•mL-1 methacholine) in each year during the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| course of follow-up. W: wheezing phase; C: cough phase; F: |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| symptom-free phase; ND: not done. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Among the annual values of PD20 in each individual of |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Group 1, geometric mean (range of 1 SD) of PD20 in the |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| years of the wheezing phase (32.8 BU, 11.5-93.3) was |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| significantly (p&lt;0.01) lower than the initial values (60.8 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| BU, 29.2-126.5); however, the values in the years of |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cough phase (68.9 BU, 27.8-170.6) were not significantly |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| different from the corresponding initial values (72.1 BU, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 34.0-153.1) (fig. 2). The changes in PD20 between the |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| two consecutive years were assessed according to whe- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ther there was a change in symptom presentation. From |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the years of cough phase to the years of wheezing phase |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (n=14), a significant decrease in PD20 was noted (54.3 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| BU, 24.0-123.0 versus 29.9 BU, 10.8-82.6; p&lt;0.01); |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| whereas, between the 2 yrs of cough phase (n=19), no |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| significant change was noted (69.5 BU, 28.4�169.8 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| versus 64.7 BU, 26.1-160.3) (data not shown). |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| In Group 2, the geometric mean of PD20 at the end of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| study (84.3 BU, 39.7-179.1) was not significantly different |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| from the initial value (85.3 BU, 45.2-161.1). Among the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| annual values of PD20 in each individual, neither the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| values in the years of cough phase (77.1 BU, 40.9-145.2) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| nor the values in the years of symptom-free phase (99.1 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| BU, 57.3-171.4) were different from the corresponding |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| initial values (81.8 BU, 40.8-164.1; 97.5 BU, 78.9-120.5, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| respectively) (fig. 3). Between the two consecutive years, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| there was no significant change in PD20 either when |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cough phase was continued (n=30; 77.6 BU, 41.2-146.2 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| versus 77.3 BU, 40.1-148.9) or when cough phase was |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| converted to symptom-free phase (n=7; 96.4 BU, 66.1- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 140.6 versus 93.8 BU, 56.4�156.0) (data not shown). The |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| changes in PD20 between the two yrs of symptom-free |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| phase (n=3) or from symptom-free phase to cough phase |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (n=2) could not be statistically analysed because of the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| small number. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The changes of wheezing threshold from the initiation to |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| the end of the study are shown in fig. 4. In Group 1, 3 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| subjects at the initiation and at the end of the study, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| respectively, necessitated the censored values; in Group |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 2, 3 subjects at the initiation and two subjects at the end of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the study necessitated the censored values. The cumula- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tive dose of methacholine that caused wheezing was |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| significantly different between the two periods in Group |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 1000 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 100 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 10 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 1 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| Initial Wheezing Initial Cough |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| Fig. 2. - The changes of methacholine provocative cumulative dose |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| producing a 20% fall in forced expiratory volume in one second (FEV1) |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| (PD20) from the initial values to those in the years of the wheezing phase |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| (left) (n=16, p&lt;0.01) or to those in the years of the cough phase (right) |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| (n=21, p=0.68) among the annual values of PD20 in each individual of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| Group 1. The mean�1SD are indicated with horizontal bars. BU: breath |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| unit (one BU denotes one inhalation of 1 mg•mL-1 methacholine). |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| 306	Y.Y. KOH ET AL. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 1000 	60 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 100 	50 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 10	40 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 30 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 20 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 10 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 0 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 1 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| Initial	Cough	Initial Symptom- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| free |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| Fig. 3 — The changes of methacholine provocative cumulative dose |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| producing a 20% fall in forced expiratory volume in one second (FEV1) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| (PD20) from the initial values to those in the years of the cough phase |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| (left) (n=37, p=0.48) or to those in the years of the symptom-free phase |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| (right) (n=10, p=0.93) among the annual values of PD20 in each |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| individual of Group 2. Mean�1 SD are indicated with horizontal bars. BU: |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| breath unit (one BU denotes one inhalation of 1 mg•mL-1 methacholine). |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 1, but the dose was not different in Group 2 (data not |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| shown). This was not surprising because the subjects in |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Group 1 showed a deterioration of airway responsiveness |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| at the end of the study, compared with at the initiation of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| study, i.e., a smaller dose was necessary to provoke the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| bronchoconstriction. At the initiation of the study, the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing thresholds were comparable between the two |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| groups. There was no significant change in wheezing |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| thresholds from the initiation to the end of study either in |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Group 1 (40.9�8.2% versus 40.2�8.3%) or in Group 2 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (41.4�7.1% versus 40.1�7.3%). The changes were not |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| significant even when the cases necessitating the cen- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sored value were excluded (Group 1: 41.2�7.4% versus |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 41.6�6.3%; Group 2: 42.2�6.5% versus 42.1�5.8%). |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sectionHeader ||| Discussion |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_larger xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| In this 4-yr prospective study, it has been shown that |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| airway responsiveness to methacholine increased signifi- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cantly, but wheezing threshold remained unaltered, as |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patients with CVA developed wheezing. There was no |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| significant change in either parameter for patients who |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| stayed as CVA or who went on to no longer have asthmatic |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| symptoms. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Some authors [1, 6] have proposed that CVA probably |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| represents the milder end of the spectrum of asthma |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| reflecting a milder degree of airway hyperresponsiveness. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| CORRAO et al. [8] have shown some evidence for this |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| hypothesis through their finding a significantly lower |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| degree of airway hyperresponsiveness in CVA than in |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| CA. However, the simple comparison between the two |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| groups is likely to be biased, because the degree of airway |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| hyperresponsiveness is dependent upon the selection of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the CA patients, and the CVA patients may be a hetero- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| geneous group [17]; as exemplified with the current |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cases, some patients develop the classic signs of asthma, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| whereas others require no further treatment with resolved |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cough. In fact, the geometric mean of PD20 in the total |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patients labelled as CVA at the initiation of study tends to |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| be lower, though not statistically significant (p=0.10), |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| Initial	End	Initial	End |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| Group 1	Group 2 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_largest-2 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figureCaption ||| Fig. 4. — The changes of wheezing threshold from the initiation to the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| end of the study. Mean�1SD are indicated with horizontal bars. There |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| was no significant change either in Group 1 (n=16, p=0.69) or in Group |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| 2 (n=13, p=0.45). 0: fall in forced expiratory volume in one second |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| FEV1 &gt;50% without wheezing; 0: maximal response plateau without |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| wheezing; O: wheezing threshold. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| than that in CA patients. However, considering the fact |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| that the current authors chose mild asthma patients for the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| CA group, it is likely that a more balanced group of CA |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| would have shown greater airway hyperreactivity than the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| CVA group. The results of this study, therefore, do not |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| negate the view that CVA is just one end of the asthma |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| spectrum. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| In the present longitudinal study, airway responsiveness |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| to methacholine in patients with CVA significantly |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| increased according to the presence of clinical wheezing. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The geometric mean of PD20 at the end of wheezing years |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was significantly lower than the initial values, and 9/-16 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patients showed a decrease in PD20 of more than a single |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| two-fold concentration of methacholine, a value that is |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| considered to be significant [18]. Furthermore, between |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the two consecutive years in which cough phase was |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| followed by wheezing phase, a significant reduction of |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| PD20 was noted. It is doubted that the increased res- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ponsiveness is related to seasonal variation by allergen |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| exposure [19], because each measurement was made in |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the winter season during which the levels of the relevant |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| allergens for most of the atopic subjects (house dust |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| mites) have been found to be the lowest and the least |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| changing in South Korea [11]. Neither is it likely to result |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| from a possible long-term variability of airway respon- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| siveness, as the authors tried to eliminate supposedly |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| affecting factors such as recent exacerbations [20], viral |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| respiratory infections [21], and exposure to environ- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| mental irritants [22]. The increased responsiveness seems |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| to occur neither from variations in baseline airway calibre |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| [23] nor from change in treatment. The baseline FEV1 as |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| a percentage of the predicted value varied by no more |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| than 10% in each subject; the mean value showed no sig- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| nificant difference between the compared years. Medica- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tion added subsequently to the development of wheezing, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| i.e., inhaled cromolyn sodium or inhaled corticosteroid, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| would rather modify levels of airway responsiveness. In |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fact, the mean level of airway responsiveness in Group 2 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| remained stable for 4 yrs although the level somewhat |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| varied within individual patients. This concurs with the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| findings in stable mild-to-moderate asthmatics by other |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| WHEEZING AND INCREASE IN AIRWAY RESPONSIVENESS	307 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| investigators [24]. Although the provocation test was |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| performed in an intentionally blind manner, the grouping |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of most patients was eventually perceived to the inves- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tigator because of the different timing of the test that |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| measured wheezing threshold. It is not, however, consi- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dered to be a drawback because methacholine PD20 is an |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| objective test. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The concept of wheezing threshold is based on an |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| individual variation in the severity of airway obstruction at |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the presence of wheezing [25]. By showing that wheezing |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| threshold, measured at the initiation of study, is higher in |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patients with CVA as a whole than it is in patients with |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| CA, the findings of a previous study have been confirmed |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| [5]. The simple comparison of percentage fall in FEV1 at |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing may not be strictly fair because wheezing could |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| have been heard at a concentration of methacholine lying |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| between the current and the previous one. However, the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| authors do not believe that their findings are due to |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| overestimation of wheezing threshold for the CVA group, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| i.e., wheezing had occurred with the FEV1 closer to that |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| at one previous concentration. Baseline airway calibre |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| may influence the level of the wheezing threshold be- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cause the level is measured as a percentage fall from the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| baseline value. There was, however, no significant dif- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ference in baseline FEV1 as a percentage of predicted |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| value between the two compared groups. The censored |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| value, which was adopted when wheezing was not audi- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ble in the stepwise airway narrowing procedure, implies |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| an underestimation of the wheezing threshold. However, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| this approach would not significantly affect the compar- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ison. In fact, the difference between the two groups was |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| still significant when those cases were excluded from the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| analysis. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Over the years of the follow-up, wheezing threshold |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| level did not change significantly in patients with CVA. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The factors discussed above might have complicated the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| comparison, but baseline FEV1 and the number of cases |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| necessitating the censored value were similar between the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| two periods for each studied group. The maintenance of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the wheezing threshold at a higher level in patients who |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were converted from CVA to CA (Group 1) as well as in |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| patients who stayed as CVA or who came to no longer |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| have asthmatic symptoms (Group 2) suggests that the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| development of wheezing in patients with CVA is not |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| associated with a decrease in the wheezing threshold. Now |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| that a higher wheezing threshold is found in CA patients |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| who are converted from CVA than that in those who have |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the same type of disease all along, it is not the unique |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| characteristic of CVA. It is proposed that the degree of the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| wheezing threshold as an individual trait may determine |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the pattern of symptom development in asthma. Another |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| inference that can be drawn from the results is that the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| presence of wheezing in patients who previously experi- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| enced CVA may imply more severe airway obstruction |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| than that in patients who did not. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The mechanism by which the development of wheezing |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| in patients with cough variant asthma is associated with an |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| increase in airway hyperresponsiveness is not clear but |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| speculative. Previous studies have shown a significant in- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| verse correlation between methacholine or histamine thres- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| hold value and peak expiratory flow rate (PEF) variability |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in asthmatic subjects [26] as well as in subjects with |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| episodic cough, dyspnoea or wheezing who showed mild |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| to moderate hyperresponsiveness [27]. A significant cor- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| relation was more recently detected between the severity |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| of airway responsiveness and the parameter of isolated or |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| short-term reductions in PEF [28]. Thus, patients with a |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| mild increase in airway responsiveness may have a mild |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| increase in variability of airflow obstruction; they will |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| report cough but not wheeze if the degree of airway nar- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| rowing is not sufficient for the development of wheezing. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Longitudinal observation of children with recurrent cough |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| or wheeze indicates that episodes of cough or wheeze |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| may be associated with falls in PEF. However, children |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with wheeze have greater PEF variability and increased |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| prevalence of airway hyperresponsiveness [29]. One study |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of asthma exacerbation induced by corticosteroid with- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| drawal indicated that symptoms could deteriorate before |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| changes in PEF, and that cough could be one of the first |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| signals of asthma exacerbation in this setting [30]. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Although the increase in airway responsiveness in pa- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| tients with CVA paralleled the development of wheezing as |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| a whole in Group 1, it should be noted that some patients |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| exhibited no change or even a decrease. One possible |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| explanation of this is that the severity of airflow obst- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ruction in asthma may be determined by the interaction of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| airway responsiveness and the strength of a bronchocon- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| striction stimulus [31]. Thus, changes in the state of asth- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ma might rather be the result of variation in the latter than |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in the former. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| In conclusion, the increased degree of airway hyper- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| reactivity during the course of cough variant asthma may |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| have a pathogenetic role in the development of wheezing, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| probably via increased variability of airflow obstruction. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| This strengthens the suggestion that different expressions |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of those factors that contribute to development and |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| maintenance of airway disease place each child on a |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| different part of the asthma spectrum and as a consequence |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lead to the observed difference in the manifestation of the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| disease [32]. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sectionHeader ||| References |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 1.	O'Connell EJ, Rojas AR, Sachs MI. Cough-type asthma: |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| a review. Ann Allergy 1991; 66: 278-285. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 2.	Pender ES, Pollack CV. Cough-variant asthma in children |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| and adults: case reports end review. JEmerg Med 1990; 8: |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 727-731. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 3.	Jones A, Sykes A. The effect of symptom presentation on |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| delay in asthma diagnosis in children in a general |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| practice. Respir Med 1990; 84: 139-142. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 4.	Gavriely N, Palti Y, Alroy G, Grotberg JB. Measurement |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| and theory of wheezing breath sounds. J Appl Physiol |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 1984; 57: 481-492. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 5. Koh YY, Chae SA, Min KU. Cough variant asthma is |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| associated with a higher wheezing threshold than classic |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| asthma. Clin Exp Allergy 1993; 23: 696-701. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 6.	Konig P. Cough variant asthma. JAsthma 1991; 28: 83- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 84. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 7.	Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bron- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| chial responsiveness to histamine: relationship to diurnal |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| variation of peak flow rate, improvement after broncho- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| dilator, and airway calibre. Thorax 1982; 37: 423-429. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 8.	Corrao WM, Braman SS, Irwin RS. Chronic cough as the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| sole presenting manifestation of bronchial asthma. NEngl |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| JMed 1979; 300: 633-637. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 9. Hannaway PJ, Hopper DK. Cough variant asthma in |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| childhood. J Am Med Ass 1982; 247: 206�208. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
note ||| 308	Y.Y. KOH ET AL. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 10. Konig P. Hidden asthma in childhood. Am J Dis Child |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 1981; 135: 1053-1055. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 11. Paik YH, Cho YJ, You TH, Bae CW, Ahn CI. The |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| seasonal variation of house dust mite allergen and the |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| incidence of bronchial asthma among children. J Korean |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Med Assoc 1991; 34: 69-77. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 12. Sheffer AL. Guidelines for the diagnosis and management |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| of asthma. VII. Management of asthma. J Allergy Clin |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Immunol 1991; 88: 477-492. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 13. Chai H, Farr RS, Froelich LA, et al. Standardization of |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| bronchial inhalation challenge procedures. JAllergy Clin |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Immunol 1975; 56: 323-327. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 14. DeVries K, Goei JT, Booy-Noord H, Orie NGM. Changes |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| during 24 hours in the lung function and histamine |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| hyperreactivity of the bronchial tree in asthmatic and |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| bronchitic patients. Int Arch Allergy Appl Immunol 1962; |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 20: 93-101. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 15. Yoon KA, Lim HS, Koh YY, Kim H. Normal predicted |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| values of pulmonary function tests in Korean school-aged |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| children. JKorean Pediatr Assoc 1993; 36: 25-37. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 16. Sterk PJ, Bel EH. Bronchial hyperresponsiveness: the |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| need for a distinction between hypersensitivity and exces- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| sive airway narrowing. Eur Respir J 1989; 2: 267-274. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 17. Johnson D, Osborn LM. Cough variant asthma: a review |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| of the clinical literature. JAsthma 1991; 28: 85-90. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 18. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| Hargreave FE. Reproducibility and comparison of res- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| ponses to inhaled histamine and methacholine. Thorax |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 1978; 33: 705-710. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 19. Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Allergen-induced increase in non-allergic bronchial reac- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| tivity. Clin Allergy 1977; 7: 503-513. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 20. Geubelle F, Borlee-Hermans G, Leclercq-Foucart J. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Hyperreactivity of the bronchial tree to histamine in as- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| thmatic children and its variations. Bull Eur Physiopathol |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Respir 1971; 7: 839-840. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 21. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Mechanisms of bronchial hyperreactivity in normal sub- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| jects after upper respiratory tract infection. Am Rev Respir |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Dis 1976; 113: 131-139. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 22. Golden JA, Nadel JA, Boushey HA. Bronchial hyper- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| irritability in healthy subjects after exposure to ozone. Am |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Rev Respir Dis 1978; 118: 287-294. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 23. Rubinfeld AR, Pain MCF. Relationship between bron- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| chial reactivity, airway caliber and severity of asthma. Am |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Rev Respir Dis 1977; 115: 381-387. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 24. Juniper EF, Frith PA, Hargreave FE. Long-term stability |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| of bronchial responsiveness to histamine. Thorax 1982; |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 37: 288-291. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 25. Shim CS, Williams MH. Relationship of wheezing to the |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| severity of obstruction in asthma. Arch Intern Med 1983; |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 143: 890-892. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 26. Brand PLP, Postma DS, Kerstjens HAM, Koeter GH, and |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| the Dutch CNSLD Study Group. Relationship of airway |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| hyperresponsiveness to respiratory symptoms and diurnal |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| peak flow variation in patients with obstructive lung |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| disease. Am Rev Respir Dis 1991; 143: 916-921. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 27. Bahous J, Cartier A, Malo JL. Monitoring of peak ex- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| piratory flow rates in subjects with mild airway hy- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| perexcitability. Bull Eur Physiopathol Respir 1985; 21: |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 25-30. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 28. Brand PLP, Duiverman EJ, Postma DS, et al. Peak flow |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| variation in childhood asthma: relationship to symptoms, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| atopy, airways obstruction and hyperresponsiveness. Eur |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Respir J 1997; 10: 1242-1247. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 29. Clough JB, Sly PD. Association between lower res- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| piratory tract symptoms and falls in peak expiratory flow |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| in children. Eur Respir J 1995; 8: 718-722. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 30. Gibson PG, Wong BJO, Hepperle MJE, et al. A research |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| method to induce and examine a mild exacerbation of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| asthma by withdrawal of inhaled corticosteroid. Clin Exp |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Allergy 1992; 22: 525-532. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 31. Killian D, Cockcroft DW, Hargreave FE, Dolovich J. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Factors in allergen-induced asthma: relevance of the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| intensity of the airways allergic reaction and nonspecific |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| bronchial reactivity. Clin Allergy 1976; 6: 219-225. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 32. Sporik R, Holgate ST, Cogswell JJ. Natural history of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| asthma in childhood-a birth cohort study. Arch Dis Child |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 1991; 66: 1050-1053. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue

